Who
Nantahala Capital Management, LLC
10% owner and Other role
Company insider
Files Form 4 as: 10% owner and Other, Talphera; 10% owner, Imageware Systems; 10% owner, Sucampo Pharmaceuticals.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $1.8M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 23 Apr 2012
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | $2.5M4,266,211 at $0.585 | filing |
| 31 Mar 2025filed 2 Apr 2025 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code A | $2.5M4,266,211 at $0.59 | filing |
| 19 Mar 2024filed 21 Mar 2024 | TLPH Talpheraoption or derivative · Biotechnology | SEC FORM 4 Code J | —324,675 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Imageware Systemsoption or derivative | SEC FORM 4 Code P | $7.5M7,500 at $1,000.00 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Imageware Systemsoption or derivative | SEC FORM 4 Code J | $7.5M750 at $10,000.00 | filing |
| 12 Nov 2020filed 16 Nov 2020 | Imageware Systemsoption or derivative | SEC FORM 4 Code J | $7.5M7,500 at $1,000.00 | filing |
| 23 Apr 2012filed 24 Apr 2012 | Sucampo Pharmaceuticals | SEC FORM 4 Sold | $511K61,891 at $8.25 | filing |
| 23 Apr 2012filed 24 Apr 2012 | Sucampo Pharmaceuticals | SEC FORM 4 Sold | $1.0M124,389 at $8.25 | filing |
| 23 Apr 2012filed 24 Apr 2012 | Sucampo Pharmaceuticals | SEC FORM 4 Sold | $277K33,620 at $8.25 | filing |
| 23 Apr 2012filed 24 Apr 2012 | Sucampo Pharmaceuticals | SEC FORM 4 Sold | —0 at $8.25 | filing |
| 23 Apr 2012filed 24 Apr 2012 | Sucampo Pharmaceuticals | SEC FORM 4 Sold | —0 at $8.25 | filing |
News
No headline names them, or the companies they trade most, lately.